Aarey Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE198H01019
  • NSEID: AAREYDRUGS
  • BSEID: 524412
INR
76.43
-4.02 (-5.0%)
BSENSE

Dec 05

BSE+NSE Vol: 36.48 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 933527,
    "name": "Aarey Drugs",
    "stock_name": "Aarey Drugs",
    "full_name": "Aarey Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/aarey-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "76.43",
    "chg": -4.02,
    "chgp": "-5.0%",
    "dir": -1,
    "prev_price": "80.45",
    "mcapval": "218.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524412,
    "symbol": "AAREYDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE198H01019",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "36.48 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarey-drugs-933527-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3746054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3746054.png",
        "date": "2025-12-04 10:00:16",
        "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed intense selling pressure on 4 December 2025, resulting in the stock hitting its lower circuit price limit of ₹73.49. The pharmaceutical and biotechnology company’s shares declined by 5.0% intraday, marking the maximum permissible daily loss and reflecting a sharp negative sentiment among investors."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3745889",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_only_sellers_3745889.png",
        "date": "2025-12-04 09:36:20",
        "description": "Aarey Drugs & Pharmaceuticals has encountered significant selling pressure, with the stock registering a sharp decline of 4.99% today and exhibiting a complete absence of buyers. This marks the third consecutive day of losses, reflecting distress selling signals and a challenging trading environment for the pharmaceutical company."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3743529",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3743529.png",
        "date": "2025-12-03 10:00:17",
        "description": "Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 3 December 2025, reflecting intense selling pressure and a sharp decline in investor confidence. The stock closed at ₹77.36, marking a maximum daily loss of 5.01%, significantly underperforming both its sector and the broader market indices."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-faces-severe-selling-pressure-amid-lower-circuit-3743401",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_only_sellers_3743401.png",
        "date": "2025-12-03 09:50:51",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has encountered significant selling pressure today, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the pharmaceutical company’s shares continue to underperform relative to broader market indices and sector benchmarks."
      },
      {
        "title": "Why is Aarey Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aarey-drugs-fallingrising-3742555",
        "imagepath": "",
        "date": "2025-12-03 00:59:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>The stock’s fall on 02-Dec represents a significant underperformance compared to its sector and benchmark indices. While the Sensex recorded a modest gain of 0.65% over the past week, Aarey Drugs declined by 7.37% during the same period. This downward trend extended into the month, with the stock falling 11.17% against the Sensex’s 1.43% rise. The intraday volatility was elevated at 5.24%, signalling considerable price fluctuations throughout the trading session. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting selling pressure dominated the session.</p>\n<p>Despite this short-term weakness, the stock remains well supported by its longer-term fundamentals. It con..."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3741866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_stocks_hitting_lower_circuit_3741866.png",
        "date": "2025-12-02 14:00:08",
        "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed a sharp decline on 2 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed at ₹81.44, marking a 5.0% drop on the day and continuing a downward trend that has seen the stock lose over 10% in the past five sessions."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-faces-severe-selling-pressure-amid-lower-circuit-3741835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_only_sellers_3741835.png",
        "date": "2025-12-02 13:30:46",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has encountered significant selling pressure today, with the stock registering a sharp decline of 4.88% and exhibiting a complete absence of buyers. This extreme selling activity signals distress within the stock, contrasting sharply with the broader market's relatively muted movement."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-faces-intense-selling-pressure-amid-lower-circuit-lockdown-3737800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_only_sellers_3737800.png",
        "date": "2025-12-01 09:45:43",
        "description": "Aarey Drugs & Pharmaceuticals Ltd has encountered significant selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading day. The pharmaceutical company’s shares have recorded consecutive declines, signalling distress selling and a challenging market environment for the stock."
      },
      {
        "title": "Aarey Drugs & Pharmaceuticals: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-downgraded-to-strong-sell-amid-weak-financials-and-mixed-technicals-3737587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AareyDrugsPharm_mojoScore_3737587.png",
        "date": "2025-12-01 08:09:07",
        "description": "Aarey Drugs & Pharmaceuticals has experienced a revision in its market assessment following a detailed review of its quality, valuation, financial trends, and technical indicators. Despite recent quarterly setbacks and cautious financial metrics, the stock’s long-term returns and evolving technical signals have influenced a nuanced shift in analytical perspective."
      }
    ],
    "total": 540,
    "sid": "933527",
    "stock_news_url": "https://www.marketsmojo.com/news/aarey-drugs-pharmaceuticals-933527"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Newspaper Publication of the Unaudited Financial Results",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter & Half Year Ended On 30Th Sept 2025",
      "datetime": "13-Nov-2025",
      "details": "Approval of Unaudited Financial results for the quarter & half year ended on 30th Sept 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025",
      "datetime": "13-Nov-2025",
      "details": "Outcome of Board meeting for approval of Unaudited Financial Results for the quarter and half year ended 30th September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 13 Dec 18",
          "dt": "2018-12-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 25 Jun 12",
          "dt": "2012-06-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>2:1</strong> rights issue, ex-date: 19 Jan 12",
          "dt": "2012-01-19",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views

Why is Aarey Drugs falling/rising?

2025-12-03 00:59:57

Short-Term Price Movement and Market Context

The stock’s fall on 02-Dec represents a significant underperformance compared to its sector and benchmark indices. While the Sensex recorded a modest gain of 0.65% over the past week, Aarey Drugs declined by 7.37% during the same period. This downward trend extended into the month, with the stock falling 11.17% against the Sensex’s 1.43% rise. The intraday volatility was elevated at 5.24%, signalling considerable price fluctuations throughout the trading session. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting selling pressure dominated the session.

Despite this short-term weakness, the stock remains well supported by its longer-term fundamentals. It con...

Read More
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

15-Nov-2025 | Source : BSE

Newspaper Publication of the Unaudited Financial Results

Unaudited Financial Results For The Quarter & Half Year Ended On 30Th Sept 2025

13-Nov-2025 | Source : BSE

Approval of Unaudited Financial results for the quarter & half year ended on 30th Sept 2025

Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025

13-Nov-2025 | Source : BSE

Outcome of Board meeting for approval of Unaudited Financial Results for the quarter and half year ended 30th September 2025

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Aarey Drugs & Pharmaceuticals Ltd has declared 1% dividend, ex-date: 13 Dec 18

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Aarey Drugs & Pharmaceuticals Ltd has announced 1:5 bonus issue, ex-date: 25 Jun 12

stock-summary
RIGHTS

Aarey Drugs & Pharmaceuticals Ltd has announced 2:1 rights issue, ex-date: 19 Jan 12